Baranowski Lyn
Chief Executive Officer
DirectorOfficer
Latest Insider Transactions
10 transactions (past 365 days)
| 2026-11-19 | 2026-11-17 | AVLN Avalyn Pharma Inc. | CEO | Sale | 5,300 | $28.15 | $149,200 |
| 2026-11-19 | 2026-11-17 | AVLN Avalyn Pharma Inc. | CEO | Sale | 39,600 | $27.76 | $1,099,296 |
| 2026-11-19 | 2026-11-18 | AVLN Avalyn Pharma Inc. | CEO | Sale | 6,465 | $27.91 | $180,406 |
| 2026-11-19 | 2026-11-18 | AVLN Avalyn Pharma Inc. | CEO | Exercise Conversion | 7,200 | $4.62 | $33,264 |
| 2026-11-19 | 2026-11-18 | AVLN Avalyn Pharma Inc. | CEO | Sale | 735 | $28.36 | $20,848 |
| 2026-11-19 | 2026-11-17 | AVLN Avalyn Pharma Inc. | CEO | Sale | 400 | $29.23 | $11,690 |
| 2026-11-19 | 2026-11-17 | AVLN Avalyn Pharma Inc. | CEO | Exercise Conversion | 45,300 | $4.62 | $209,286 |
| 2026-11-19 | 2026-11-18 | AVLN Avalyn Pharma Inc. | CEO | Exercise Conversion | 7,200 | $4.62 | $33,264 |
| 2026-11-19 | 2026-11-17 | AVLN Avalyn Pharma Inc. | CEO | Exercise Conversion | 45,300 | $4.62 | $209,286 |
| 2026-05-01 | 2026-04-29 | AVLN Avalyn Pharma Inc. | CEO | Award | 501,033 | $18.00 | $9,018,594 |
AVLN
CEO
Exercise Conversion
$33.3K
7,200 shares @ $4.62
Filed 2026-11-19Trade 2026-11-18
Avalyn Pharma Inc.AVLN
CEO
Exercise Conversion
$209.3K
45,300 shares @ $4.62
Filed 2026-11-19Trade 2026-11-17
Avalyn Pharma Inc.AVLN
CEO
Exercise Conversion
$33.3K
7,200 shares @ $4.62
Filed 2026-11-19Trade 2026-11-18
Avalyn Pharma Inc.AVLN
CEO
Exercise Conversion
$209.3K
45,300 shares @ $4.62
Filed 2026-11-19Trade 2026-11-17
Avalyn Pharma Inc.